Skip to main content

and
  1. Article

    Open Access

    Correction to: Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use

    An amendment to this paper has been published and can be accessed via the original article.

    Vicky Wilkinson, Kotaro Takano, David Nichols, Alynn Martin in Parasites & Vectors (2021)

  2. Article

    Open Access

    Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use

    Sarcoptic mange causes significant animal welfare and occasional conservation concerns for bare-nosed wombats (Vombatus ursinus) throughout their range. To date, in situ chemotherapeutic interventions have involv...

    Vicky Wilkinson, Kotaro Takano, David Nichols, Alynn Martin in Parasites & Vectors (2021)

  3. Article

    Open Access

    Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils

    Devil facial tumour disease (DFTD) is a transmissible cancer devastating the Tasmanian devil (Sarcophilus harrisii) population. The cancer cell is the ‘infectious’ agent transmitted as an allograft by biting. Ani...

    Cesar Tovar, Ruth J. Pye, Alexandre Kreiss, Yuanyuan Cheng in Scientific Reports (2017)

  4. Article

    The Immune Response of the Tasmanian Devil (Sarcophilus harrisii) and Devil Facial Tumour Disease

    One of the most remarkable aspects of Devil Facial Tumour Disease (DFTD) is its infectious nature, and for successful transmission it must avoid detection by the devil’s immune system. For this to occur, the d...

    Gregory M. Woods, Alexandre Kreiss, Katherine Belov, Hannah V. Siddle in EcoHealth (2007)